![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Zhejiang Changming Pharmaceutical Co., Ltd. Tiantai Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Valsartan, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2014-162 - Rev 00
This Chemical Type CEP, issued on November 03, 2016, remains in force until October 26, 2020, ensuring its reliability within the pharmaceutical industry.
Substance Number 2423 associated with this CEP further emphasizes